Intestinal necrosis after co-administration of sodium polystyrene sulfonate and activated charcoal

Abstract

Development of acute abdominal pain after Kayexalate and activated charcoal administration should prompt clinician to consider intestinal necrosis. Concomitant use should be avoided to minimize the risk of this devastating but preventable condition.

Keywords: activated charcoal; end‐stage renal disease; intentional drug overdose; kayexalate; kidney transplant.